Search research articles
Contact Us
Filters
Showing results (251-260 of 383) with videos related to
Page
of 39
Sort By:
Breast Cancer Research and Treatment
|
December 20, 2023
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, et al.
Oncotarget
|
April 23, 2016
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
Barbara Brouwers, Sigrid Hatse, Lissandra Dal Lago, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2017
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
George W Sledge, Masakazu Toi, Patrick Neven, et al.
Breast Cancer Research and Treatment
|
October 25, 2006
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging
Leilani Morales, Steven Pans, Robert Paridaens, et al.
The New England Journal of Medicine
|
February 26, 2010
Lasofoxifene in postmenopausal women with osteoporosis
Steven R Cummings, Kristine Ensrud, Pierre D Delmas, et al.
JAMA Oncology
|
September 11, 2015
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
Frédéric Amant, Magali Verheecke, Iwona Wlodarska, et al.
Geroscience
|
August 26, 2023
Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty
Qi Wu, Sigrid Hatse, Cindy Kenis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 26, 2025
Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial
Giacomo Biganzoli, Edoardo Isnaldi, François Richard, et al.
Future Oncology (London, England)
|
June 13, 2022
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, et al.
Journal of the National Cancer Institute
|
November 6, 2010
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women
Andrea Z LaCroix, Trevor Powles, C Kent Osborne, et al.
Page
of 39
Search research articles
Search
Showing results (251-260 of 383) with videos related to
Sort By:
Page
of 39
Breast Cancer Research and Treatment
|
December 20, 2023
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, et al.
Oncotarget
|
April 23, 2016
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
Barbara Brouwers, Sigrid Hatse, Lissandra Dal Lago, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2017
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
George W Sledge, Masakazu Toi, Patrick Neven, et al.
Breast Cancer Research and Treatment
|
October 25, 2006
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging
Leilani Morales, Steven Pans, Robert Paridaens, et al.
The New England Journal of Medicine
|
February 26, 2010
Lasofoxifene in postmenopausal women with osteoporosis
Steven R Cummings, Kristine Ensrud, Pierre D Delmas, et al.
JAMA Oncology
|
September 11, 2015
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
Frédéric Amant, Magali Verheecke, Iwona Wlodarska, et al.
Geroscience
|
August 26, 2023
Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty
Qi Wu, Sigrid Hatse, Cindy Kenis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 26, 2025
Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial
Giacomo Biganzoli, Edoardo Isnaldi, François Richard, et al.
Future Oncology (London, England)
|
June 13, 2022
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, et al.
Journal of the National Cancer Institute
|
November 6, 2010
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women
Andrea Z LaCroix, Trevor Powles, C Kent Osborne, et al.
Page
of 39